Cardiovascular drugs and COVID‐19 clinical outcomes: A living systematic review and meta‐analysis

AIMS: The aim of this study was to continually evaluate the association between cardiovascular drug exposure and COVID‐19 clinical outcomes (susceptibility to infection, disease severity, hospitalization, hospitalization length, and all‐cause mortality) in patients at risk of/with confirmed COVID‐19...

Descripción completa

Detalles Bibliográficos
Autores principales: Asiimwe, Innocent G., Pushpakom, Sudeep, Turner, Richard M., Kolamunnage‐Dona, Ruwanthi, Jorgensen, Andrea L., Pirmohamed, Munir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239929/
https://www.ncbi.nlm.nih.gov/pubmed/34101232
http://dx.doi.org/10.1111/bcp.14927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239929/
https://www.ncbi.nlm.nih.gov/pubmed/34101232
http://dx.doi.org/10.1111/bcp.14927

Ejemplares similares